CTRI/2021/01/030582尚未招募未知
A real world study to evaluate the safety, immunogenicity and efficacy of COVID 19 vaccines during the national vaccination roll out among health care workers in a tertiary care hospital
Medanta Institute of Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All adults above 18 years of age who are working at Medanta The Medicity Gurgaon and are listed in the first COVID 19 vaccination list shared by Medanta HR Team with the GOI Officials will be considered for participation
排除标准
- •Participation in COVID-19 prophylactic drug trials before or during the duration study
- •Receipt of any vaccine (licensed or investigational) other than the study intervention within 14 days before and after each study vaccination
- •History of allergic disease or reactions likely to be exacerbated by any component of
- •Active ongoing laboratory confirmed COVID 19
- •Administration of immunoglobulins and/or convalescent plasma within the three months
- •preceding the planned administration of the vaccine
研究者
相似试验
招募中
1 期
A pilot study to evaluate the safety and efficacy of a personalised cancer vaccine in patients with completely resected early stage lung cancerLung CancerACTRN12619000769189niversity of Western Australia6
招募中
1 期
evaluate the safety and immunomodulatory efficacy of Byolic CC supplementImmunomodulatory effect on healthy volunteers.IRCT20240304061158N4Behpad Teb Iranian90
已完成
3 期
A Comparative Phase III Clinical Study of Bharat Biotech International Limited Rabies Vaccine INDIRAB reconstituted with 1mL diluent Vs Reference Vaccine, administered Intramuscularly in healthy volunteers as Pre-Exposure treatment.CTRI/2010/091/000214Bharat Biotech International Limited,Genome Valley, Shameerpet,Ranga Reddy (Distict),Hyderabad-500 078.60
进行中（未招募）
1 期
A phase I study to evaluate safety and immunogenicity of recombinant protein candidate vaccine against SARS-CoV-2 in healthy volunteers.SARS-CoV-2MedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862EUCTR2021-001411-82-ESABORATORIOS HIPRA, S.A.30
进行中（未招募）
1 期
A clinical trial to assess the safety, immune response, and protection against infection of novel malaria vaccines.Plasmodium falciparum infectionEUCTR2017-001049-28-GBniversity of Oxford, CTRG18